Press Releases
Announcements issued by Philogen, each linking its official release.
Philogen Announces Upcoming Calendar of Corporate Events – Third Quarter Financial Results and Corporate Update
Philogen will hold a virtual briefing on 1 December 2022 at 10:00 ET / 15:00 BST / 16:00 CEST following the Press Release of the Third Quarter Financial Results…
Philogen publishes a new study on OncoFAP in Clinical Cancer Research
The study shows excellent tumor uptake of the novel OncoFAP-MMAE Small Molecule-Drug Conjugates (SMDCs) with high and selective release of the cytotoxic MMAE…
Philogen announces publication of IL12-7NP2 (an Interleukin-12 fusion protein against Fibroblast Activation Protein) in Journal for Immunotherapy of Cancer.
The study shows selective tumor uptake of IL12-7NP2 and potent antitumor activity as single agent and in combination with immune checkpoint inhibitors. The…
Philogen to Present at Upcoming Conferences
Siena (Italy), 8 September 2022 – Philogen S.p.A. today announces the conferences its management team will be participating in the coming months.
Philogen Provides Corporate Update
Philogen’s management team will hold a webinar to discuss these updates on June 23, 2022, at 10:00 ET / 15:00 BST / 16:00 CEST (Please find the link to this…